<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02018185</url>
  </required_header>
  <id_info>
    <org_study_id>B2013:144</org_study_id>
    <nct_id>NCT02018185</nct_id>
  </id_info>
  <brief_title>Study of Magnetic Brain Stimulation in Treatment of Obsessive Compulsive Disorder</brief_title>
  <acronym>rTMS</acronym>
  <official_title>The Efficacy of Deep Repetitive Transcranial Magnetic Stimulation in Treatment of Obsessive Compulsive Disorder, a Double Blind Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Manitoba</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Manitoba Medical Service Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Manitoba</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In a preliminary pilot study, the investigators tested the efficacy of rTMS over the medial&#xD;
      prefrontal cortex in symptom profiles of obsessive compulsive disorder (OCD) patients. This&#xD;
      study revealed considerable benefit in using rTMS for the treatment of OCD.&#xD;
&#xD;
      In the current proposal, in a randomized clinical trial, the investigators aim to further&#xD;
      evaluate the efficacy of rTMS in OCD in a larger sample size and for a longer period. Studies&#xD;
      into the efficacy of rTMS in other psychiatric disorders such as depression have consistently&#xD;
      shown that extension of the treatment to four weeks significantly increased the effect size.&#xD;
      In the pilot study, the investigators applied rTMS for only two weeks. Although all patients&#xD;
      consistently showed improvement in their symptoms, none of them showed complete remission of&#xD;
      their OCD. Here, the investigators hypothesize that longer duration of rTMS treatment will&#xD;
      have greater benefit in OCD symptom reduction.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of study is to examine the efficacy of rTMS over the medial prefrontal cortex in&#xD;
      the treatment of OCD.&#xD;
&#xD;
      rTMS will be provided to OCD patients in a randomized double blind controlled setting, and&#xD;
      the investigators hypothesize that in this setting the treatment group would still show&#xD;
      significant improvement in OCD symptoms as compared to the sham group.&#xD;
&#xD;
      rTMS will be applied for four weeks on OCD patients and the investigators will assess&#xD;
      improvement after four weeks of rTMS. The investigators hypothesize that patients will show&#xD;
      significantly greater improvement after four weeks of rTMS vs. two weeks of rTMS.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    Recruitment has been suspended in order to perform interim data analysis.&#xD;
  </why_stopped>
  <start_date type="Actual">January 2014</start_date>
  <completion_date type="Anticipated">August 2021</completion_date>
  <primary_completion_date type="Actual">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in obsessive and compulsive symptom severity (Yale-Brown Obsessive Compulsive Scale)</measure>
    <time_frame>Recordings: baseline; after two weeks of rTMS; after four weeks of rTMS; monthly for three months following the last session of rTMS</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Obsessive Compulsive Disorder</condition>
  <arm_group>
    <arm_group_label>Transcranial Magnetic Stimulation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Transcranial Magnetic Stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham rTMS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham Transcranial Magnetic Stimulation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcranial Magnetic Stimulation</intervention_name>
    <description>A non-invasive method for brain stimulation</description>
    <arm_group_label>Transcranial Magnetic Stimulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham Transcranial Magnetic Stimulation</intervention_name>
    <description>Sham stimulation of the brain.</description>
    <arm_group_label>Sham rTMS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosed obsessive compulsive disorder&#xD;
&#xD;
          -  Not currently receiving cognitive behavioural therapy&#xD;
&#xD;
          -  Not currently on any medication or only taking one selective serotonin reuptake&#xD;
             inhibitor (SSRI)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of psychotic episodes&#xD;
&#xD;
          -  History of neurological illness&#xD;
&#xD;
          -  Previous head injury&#xD;
&#xD;
          -  Active alcohol or substance abuse&#xD;
&#xD;
          -  History of seizure disorders&#xD;
&#xD;
          -  Currently pregnant&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>St. Boniface Hospital</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R3P2B4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>December 10, 2013</study_first_submitted>
  <study_first_submitted_qc>December 16, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 23, 2013</study_first_posted>
  <last_update_submitted>March 22, 2021</last_update_submitted>
  <last_update_submitted_qc>March 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Compulsive Personality Disorder</mesh_term>
    <mesh_term>Obsessive-Compulsive Disorder</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>October 1, 2021</submitted>
    <returned>October 29, 2021</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

